DK0796848T3 - Fluoralkyl- og fluoralkoxysubstituerede heterocykliske bradykinin-antagonister - Google Patents
Fluoralkyl- og fluoralkoxysubstituerede heterocykliske bradykinin-antagonisterInfo
- Publication number
- DK0796848T3 DK0796848T3 DK97103611T DK97103611T DK0796848T3 DK 0796848 T3 DK0796848 T3 DK 0796848T3 DK 97103611 T DK97103611 T DK 97103611T DK 97103611 T DK97103611 T DK 97103611T DK 0796848 T3 DK0796848 T3 DK 0796848T3
- Authority
- DK
- Denmark
- Prior art keywords
- fluoroalkyl
- substituted heterocyclic
- bradykinin antagonists
- fluoroalkoxy substituted
- fluoroalkoxy
- Prior art date
Links
- 239000003152 bradykinin antagonist Substances 0.000 title 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 title 1
- 125000003709 fluoroalkyl group Chemical group 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D257/12—Six-membered rings having four nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19610784A DE19610784A1 (de) | 1996-03-19 | 1996-03-19 | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0796848T3 true DK0796848T3 (da) | 2003-09-22 |
Family
ID=7788755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97103611T DK0796848T3 (da) | 1996-03-19 | 1997-03-05 | Fluoralkyl- og fluoralkoxysubstituerede heterocykliske bradykinin-antagonister |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5859025A (cs) |
| EP (1) | EP0796848B1 (cs) |
| JP (1) | JP4199315B2 (cs) |
| KR (1) | KR970065522A (cs) |
| AR (1) | AR006261A1 (cs) |
| AT (1) | ATE242215T1 (cs) |
| AU (1) | AU1628397A (cs) |
| BR (1) | BR9701332A (cs) |
| CA (1) | CA2199925A1 (cs) |
| CZ (1) | CZ81097A3 (cs) |
| DE (2) | DE19610784A1 (cs) |
| DK (1) | DK0796848T3 (cs) |
| ES (1) | ES2196207T3 (cs) |
| HR (1) | HRP970155A2 (cs) |
| HU (1) | HUP9700595A1 (cs) |
| ID (1) | ID16274A (cs) |
| IL (1) | IL120477A0 (cs) |
| NO (1) | NO971238L (cs) |
| PL (1) | PL318924A1 (cs) |
| PT (1) | PT796848E (cs) |
| SI (1) | SI0796848T1 (cs) |
| SK (1) | SK34897A3 (cs) |
| TR (1) | TR199700206A2 (cs) |
| ZA (1) | ZA972328B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| DK1106614T3 (da) * | 1999-12-10 | 2004-04-13 | Pfizer | 5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister |
| EP1914236A1 (en) | 2002-04-10 | 2008-04-23 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| JP2005525398A (ja) * | 2002-04-10 | 2005-08-25 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ブラジキニン受容体モジュレーターとして有用な新規なヘテロアリールアルキルアミド誘導体 |
| ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| US7256207B2 (en) * | 2003-08-20 | 2007-08-14 | Irm Llc | Inhibitors of cathepsin S |
| RU2007131400A (ru) | 2005-03-01 | 2009-04-10 | Вайет (Us) | Соединения циннолина и их применение в качестве модуляторов х-рецепторов печени |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR085073A1 (es) * | 2012-01-11 | 2013-09-11 | Richmond Sa Com Ind Y Financiera Lab | Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden |
| AR113839A1 (es) | 2017-11-24 | 2020-06-17 | Pharvaris B V | Antagonistas del receptor b2 de bradiquinina |
| UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| MA61123B1 (fr) | 2021-08-05 | 2024-06-28 | Pharvaris Gmbh | Composition à base de lipides pour l'administration par voie orale d'antagonistes des récepteurs b2 de la bradykinine |
| US20250268887A1 (en) | 2022-03-25 | 2025-08-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| ES3062067T3 (en) | 2022-03-25 | 2026-04-08 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212182A (en) * | 1990-10-03 | 1993-05-18 | American Home Products Corpooration | Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics |
| US5216165A (en) * | 1990-10-03 | 1993-06-01 | American Home Products Corporation | N-substituted aminoquinolines as analgesic agents |
| US5438064A (en) * | 1991-12-23 | 1995-08-01 | American Home Products Corporation | Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| WO1996005202A1 (en) * | 1994-08-17 | 1996-02-22 | Nippon Hypox Laboratories Inc. | Imidazoquinoline derivative |
| ES2218554T3 (es) * | 1994-10-27 | 2004-11-16 | Fujisawa Pharmaceutical Co., Ltd. | Piridopirimidonas, quinolinas y n-heterociclos condensados que son antagonistas de bradiquinina. |
-
1996
- 1996-03-19 DE DE19610784A patent/DE19610784A1/de not_active Withdrawn
-
1997
- 1997-03-05 PT PT97103611T patent/PT796848E/pt unknown
- 1997-03-05 DK DK97103611T patent/DK0796848T3/da active
- 1997-03-05 ES ES97103611T patent/ES2196207T3/es not_active Expired - Lifetime
- 1997-03-05 EP EP97103611A patent/EP0796848B1/de not_active Expired - Lifetime
- 1997-03-05 DE DE59710191T patent/DE59710191D1/de not_active Expired - Lifetime
- 1997-03-05 SI SI9730572T patent/SI0796848T1/xx unknown
- 1997-03-05 AT AT97103611T patent/ATE242215T1/de not_active IP Right Cessation
- 1997-03-12 PL PL97318924A patent/PL318924A1/xx unknown
- 1997-03-13 CA CA002199925A patent/CA2199925A1/en not_active Abandoned
- 1997-03-17 ID IDP970863A patent/ID16274A/id unknown
- 1997-03-17 SK SK348-97A patent/SK34897A3/sk unknown
- 1997-03-17 AR ARP970101058A patent/AR006261A1/es unknown
- 1997-03-17 HU HU9700595A patent/HUP9700595A1/hu unknown
- 1997-03-17 AU AU16283/97A patent/AU1628397A/en not_active Abandoned
- 1997-03-17 KR KR1019970008899A patent/KR970065522A/ko not_active Withdrawn
- 1997-03-17 CZ CZ97810A patent/CZ81097A3/cs unknown
- 1997-03-17 TR TR97/00206A patent/TR199700206A2/xx unknown
- 1997-03-18 IL IL12047797A patent/IL120477A0/xx unknown
- 1997-03-18 HR HR19610784.9A patent/HRP970155A2/xx not_active Application Discontinuation
- 1997-03-18 JP JP06474897A patent/JP4199315B2/ja not_active Expired - Lifetime
- 1997-03-18 NO NO971238A patent/NO971238L/no unknown
- 1997-03-18 ZA ZA9702328A patent/ZA972328B/xx unknown
- 1997-03-18 BR BR9701332A patent/BR9701332A/pt not_active Application Discontinuation
- 1997-03-18 US US08/819,351 patent/US5859025A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| TR199700206A2 (xx) | 1997-10-21 |
| CA2199925A1 (en) | 1997-09-19 |
| BR9701332A (pt) | 1998-08-18 |
| ID16274A (id) | 1997-09-18 |
| KR970065522A (ko) | 1997-10-13 |
| JPH107656A (ja) | 1998-01-13 |
| PL318924A1 (en) | 1997-09-29 |
| EP0796848A1 (de) | 1997-09-24 |
| AR006261A1 (es) | 1999-08-11 |
| JP4199315B2 (ja) | 2008-12-17 |
| NO971238L (no) | 1997-09-22 |
| EP0796848B1 (de) | 2003-06-04 |
| ES2196207T3 (es) | 2003-12-16 |
| AU1628397A (en) | 1997-09-25 |
| DE59710191D1 (de) | 2003-07-10 |
| US5859025A (en) | 1999-01-12 |
| CZ81097A3 (en) | 1997-10-15 |
| ATE242215T1 (de) | 2003-06-15 |
| PT796848E (pt) | 2003-08-29 |
| SK34897A3 (en) | 1998-01-14 |
| SI0796848T1 (en) | 2003-12-31 |
| HUP9700595A1 (hu) | 2000-08-28 |
| MX9702028A (es) | 1997-09-30 |
| HU9700595D0 (en) | 1997-05-28 |
| DE19610784A1 (de) | 1997-09-25 |
| ZA972328B (en) | 1997-09-19 |
| HRP970155A2 (en) | 1998-04-30 |
| NO971238D0 (no) | 1997-03-18 |
| IL120477A0 (en) | 1997-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9703890A (pt) | Piridinas heterocíclicas fundidas | |
| ATE233260T1 (de) | Muscarin-antagonisten | |
| FI932518A7 (fi) | Angiotensiinin II antagonistit | |
| DK0796848T3 (da) | Fluoralkyl- og fluoralkoxysubstituerede heterocykliske bradykinin-antagonister | |
| NO932005D0 (no) | Angiotensin-ii-antagonister | |
| DE69730833D1 (de) | Photochrome heterocyclische annelierte indenonaphthopyrane | |
| BR9700702A (pt) | Tienil e furanil-oxazolidinonas pirido-fundidas | |
| NO991813L (no) | Anvendelse av ikke-peptid NK3 antagonister | |
| DE69716615D1 (de) | Heterozyklische metalloproteaseinhibitoren | |
| KR100345626B1 (ko) | 안지오텐신ii길항물질로서의치환된인돌및아자인돌 | |
| DE69717967D1 (de) | Heterocyclische kondensierte morphin-derivate | |
| DK0900210T3 (da) | Antiviralt aktive heterocykliske azahexanderivater | |
| ATE206445T1 (de) | Rheologisch modifizierte polyolefine | |
| DE69721528D1 (de) | Persönlicher überwachungsanhänger | |
| EP0934305A4 (en) | INTEGRINANTAGONISTS | |
| DK0738150T3 (da) | Bicykliske fibrinogene antagonister | |
| DE69629547D1 (de) | Fernsensor mit Bereitschaftsbetrieb | |
| NO303590B1 (no) | L°pehjul | |
| DE69903961D1 (de) | Muscarinagonisten und antagonisten | |
| NO990552D0 (no) | Innrettingsverkt°y | |
| FI950089A7 (fi) | Dioksosyklobuteenijohdannaiset angiotensiini-II-antagonisteina | |
| NO985395D0 (no) | L°fteanordning | |
| FR2781221B1 (fr) | Piperazinones substituees en alpha | |
| DE69821651D1 (de) | Management von vermittlungstechnischen abschlusseinheiten | |
| ATE214063T1 (de) | Heterocyclische substituierte pyrrolidinamid- derivate |